1)Eaden J, Abrams K, Mayberry J. The risk of colorectal cancer in ulcerative colitis:a meta-analysis. Gut 48:526-535, 2001
2)Rutter MD, Saunders BP, Wilkinson KH, et al. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc 60:334-339, 2004
3)Rubin D, Rothe J, Hetzel J, et al. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?Gastrointest Endosc 65:998-1004, 2007
4)Rutter MD, Saunders BP, Schofield G, et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 53:256-260, 2004
5)Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 124:880-888, 2003
6)Matsumoto T, Iwao Y, Igarashi M, et al. Endoscopic and chromoscopic atlas featuring dysplastic lesions in surveillance colonoscopy for patients with long-standing ulcerative colitis. Inflamm Bowel Dis14:259-264, 2008
7)Blackstone MO, Riddell RH, Rogers BH, et al. Dysplasia-associated lesion or mass(DALM)detected by colonoscopy in long-standing ulcerative colitis:an indication for colectomy. Gastroenterology 80:366-374, 1981
8)Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance:clinical guideline and rationale-Update based on new evidence. Gastroenterology 124:544-560, 2003
9)Bernstein C, Shanahan F, Weinstein W. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?Lancet 343:71-74, 1994
10)五十嵐正広,渡邉聡明,味岡洋一.colitic cancerサーベイランスと症例の実態─アンケート結果より.渡邉聡明,味岡洋一,五十嵐正広,他(編).colitic cancer─診断と治療の現況.日本メディカルセンター,pp 149-161, 2006